Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Clinical Laboratory Testing Services (CPT-Based)

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract obligates the provider to deliver clinical laboratory testing services in full compliance with CLIA and CAP standards, specifically for specimens sourced from military personnel, with a strict 48-hour turnaround requirement for result delivery. All testing must be billed using CPT-based coding and performed to ensure accuracy, reliability, and regulatory adherence throughout the testing lifecycle. The work is to be conducted at the designated place of performance in Flowood, Mississippi, with the contract operating under a subcontract structure and governed by the NAICS code 621511, which classifies it as a clinical laboratory service. The solicitation was posted on July 28, 2026, and responses are due by August 26, 2026, with the awarding entity being the Department of Defense through its W7NH Uspfo Activity Msang 172 office.

General Info

Provider must deliver CLIA/CAP-compliant lab testing for military personnel in Flowood, MS, within 48 hours, using CPT coding.

Agency

Department Of Defense → W7NH Uspfo Activity Msang 172View Agency

NAICS

621511 - Medical LaboratoriesView NAICS

Place of Performance

Flowood, MS, 39232, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → W7NH Uspfo Activity Msang 172
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Defense → W7NH Uspfo Activity Msang 172
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Perform CLIA/CAP-compliant clinical laboratory testing on specimens from military personnel, with 48-hour turnaround for results delivery.

Similar Contracts

Same NAICS industry code

NAICS: 621511
New
Federal
172 AW Lab Services IDIQ
Solicitation # W50S7H26RA001
The U.S. Air Force’s 172d Airlift Wing is soliciting proposals for a five-year, firm-fixed-price Indefinite-Delivery, Indefinite-Quantity (IDIQ) contract under solicitation number W50S7H-26-R-A001 to obtain comprehensive medical laboratory testing services. This is a 100% small business set-aside with a size standard of $41.5 million, targeted at NAICS code 621511 for medical laboratories. Proposals must be submitted electronically by August 26, 2026, and must include a detailed price schedule covering all services listed in the Performance Work Statement, formatted in MS Excel or PDF. Pricing must reflect unit costs for all five years of the ordering period, and any transaction fees associated with Government Purchase Card (GPC) use must be explicitly stated—otherwise, no surcharges will be assumed. The contract will be awarded using the Best Value Trade-Off process under FAR 13.5 and Part 12, prioritizing technical capability and past performance over price, though price remains a critical component evaluated for reasonableness and balance. Technical proposals must demonstrate compliance with CLIA/CAP certifications, a clear operational plan for sample collection and turnaround times within a Sunday-through-Saturday 0730–1600 window, and confirmation that all laboratory facilities are within 30 minutes’ drive of the 172d Airlift Wing and strictly within the Jackson MSA. Orders under the resulting IDIQ will be placed using either the GPC for transactions up to $25,000 or DD Form 1155 Delivery Orders for amounts above that threshold, with electronic funds transfer processed through WAWF. GPC usage is the primary execution method for low-value orders to accelerate payment cycles, and only authorized cardholders designated by the 172d Medical Group may issue such orders. Contractors must accept both GPC and Delivery Order payment mechanisms, and all invoicing must comply with WAWF requirements, including the use of specified DoDAACs for payment routing. The evaluation process will rate technical capability as the most critical factor, with subfactors for licensing, operational capability, and geographic compliance acting as gatekeepers—failure in any one will render a proposal unacceptable. Past performance will be assessed for relevance and recency within the past three years, and price will be analyzed for total evaluated cost based on estimated volumes
W7NH Uspfo Activity Msang 172

POSTED

1 day ago

DEADLINE

in 28 days
View Details
NAICS: 621511
New
Federal
Q515--MO - HLA Testing - 626 Tennessee Valley Healthcare System HLA Transplant Testing Services POP: 10/1/2026-9/30/2032
Solicitation # 36C24926R0076
The Department of Veterans Affairs, through Network Contracting Office 9, has issued a solicitation for HLA Transplant Testing Services to support the Tennessee Valley Healthcare System in Nashville, Tennessee. The contract has a performance period extending from October 1, 2026, through September 30, 2032, and is identified by solicitation number 36C24926R0076 under NAICS code 621511 and Product Service Code Q515. Proposals are due by August 24, 2026, with submissions to be directed to the contracting office located in Murfreesboro, Tennessee. The primary point of contact is Contract Specialist Rebecca Espinoza, reachable via email at rebecca.espinoza@va.gov. The place of performance is the Tennessee Valley Healthcare System’s facility at 1310 24th Avenue South, Nashville, TN 37212. The solicitation is for specialized clinical laboratory services critical to organ transplant compatibility assessments, though detailed specifications, deliverables, evaluation factors, pricing terms, and contractual clauses have not yet been released in the available documentation. Information regarding inspection criteria, packaging and labeling requirements, quality standards such as CLIA or CAP, invoicing procedures, accounting data, key personnel qualifications, and special requirements including security clearances or organizational conflict of interest provisions remain unspecified and are expected to be detailed in the full solicitation package when published. No set-aside status has been designated, and no attachment lists, contract clauses, or evaluation factors are currently accessible. All cost information, line-item details, and submission formatting instructions are pending release. Offerors must await the official solicitation for comprehensive guidance on compliance, technical requirements, and award methodology.
249-NETWORK Contract Office 9 (36C249)

POSTED

1 day ago

DEADLINE

in 26 days
View Details
NAICS: 621511
New
Federal
Clinical Laboratory Testing and Specialized Biochemical AnalysisServices for the NHGRI Undiagnosed Diseases Program (UDP) through Baylor Genetics Laboratory
Solicitation # 75N98026Q00900
The contract entails the provision of CLIA-certified clinical laboratory testing and specialized biochemical analysis services for the National Human Genome Research Institute’s Undiagnosed Diseases Program, under NIH protocol 15-HG-0130, through Baylor Genetics Laboratory. The work supports the evaluation of patients with complex, rare, and previously undiagnosed multisystem disorders, focusing on genetic, metabolic, and mitochondrial conditions. Services include advanced testing such as mitochondrial DNA copy number quantification, assessment of mitochondrial deletions, metabolomic profiling, biochemical pathway analysis, and testing of tissues including muscle, liver, fibroblasts, blood, and urine, along with follow-up family studies when authorized. All testing must adhere to federal and state regulations, using validated methodologies and maintained quality assurance systems to ensure accuracy and compliance. The contractor is required to deliver comprehensive laboratory reports with clinical interpretations and limitations within established turnaround times, using secure, privacy-compliant transmission methods. Immediate notification of critical or clinically significant findings is mandatory to support urgent patient care. Technical consultation services are essential, including guidance on test selection, specimen handling, result interpretation, and recommendations for additional testing. The contractor must also actively participate in scientific and clinical discussions as requested by NIH. The solicitation, numbered 75N98026Q00900, is issued by the National Institutes of Health within the Department of Health and Human Services, with responses due by August 7, 2026, and performance primarily based in Bethesda, Maryland.
National Institutes Of Health Olao

POSTED

1 day ago

DEADLINE

in 9 days
View Details
NAICS: 621511
New
Federal
Genotyping Analysis Services
Solicitation # HT942626QE044
The US Army Army Research Institute of Environmental Medicine is seeking a vendor to perform large-scale genomic analysis on 648 DNA samples collected as part of the Military Health and Nutrition Examination Survey, using the Illumina Global Diversity Array to genotype approximately 1.8 million genome-wide SNPs. This service supports critical research operations including population genetics, ancestry inference, polygenic score calculation, and genome-wide association studies. The contractor must deliver comprehensive technical reports with full de-identified datasets within 90 days of sample receipt, alongside a finalized Quality Control Plan within 15 days of award and same-day confirmation of sample arrival. All work must adhere to Good Laboratory Practices and validated Standard Operating Procedures, with analytical accuracy requiring zero customer complaints and a minimum genotype call rate of 96.5 percent, including HapMap controls and duplicate samples for validation. The contract is expected to be awarded on a Firm-Fixed Price basis under a trade-off evaluation process prioritizing Technical Approach and Past Performance, both of which must meet an Acceptable threshold before Price is considered. Only offers that are technically acceptable and demonstrate relevant past performance with substantial or good confidence will proceed to price evaluation. The solicitation requires electronic submission of two volumes — a 10-page Technical Approach and a separate Past Performance and Price volume — via email by 9:00 AM Eastern Time on July 30, 2026, using MS Word, Excel, or searchable PDF formats with no compression. The contractor must be registered in SAM.gov and the WAWF portal for invoicing, which will be conducted electronically following DFARS requirements. Samples must be shipped as a single batch immediately after award in EDTA tubes at 0.5 mL per sample, with delivery to the destination in Natick, Massachusetts, under FOB Destination terms. The contract period of performance runs from August 4, 2026, to August 3, 2027. Contractors must comply with numerous FAR and DFARS clauses, including protections against inverted corporations, subcontracts with excluded entities, cybersecurity requirements, and prohibitions on covered telecommunications equipment. No set-aside is designated, though small business, HUBZone, SDVOSB, WOSB, EDWOSB, and 8(a) entities may compete. The government retains inspection authority at the delivery site, and all deliverables must meet the Performance Requirements Summary and Quality Assurance Surveillance Plan standards without government oversight of daily operations. Key personnel and security clearance requirements are currently reserved, and
Defense Health Agency

POSTED

2 days ago

DEADLINE

in 5 days
View Details
NAICS: 621511
New
Federal
Reference Laboratory MRD Testing PDX
Solicitation # 36C26026Q0851
The Department of Veterans Affairs is seeking a reference laboratory service provider to perform measurable residual disease (MRD) testing for hematologic malignancies including Multiple Myeloma, Chronic Lymphocytic Leukemia, and B-cell Acute Lymphoblastic Leukemia, primarily supporting the Portland VA Medical Center. The contract is a five-year firm-fixed price arrangement with a base year starting September 1, 2026, and four option years extending through August 31, 2031, with a total estimated value of $41.5 million. The contractor must operate a CLIA-certified and CAP-accredited laboratory using FDA-cleared methodologies to deliver clinically validated MRD test results within six business days on average, with specimen logging within 24 hours of receipt and final reports issued within 24 hours post-testing. All testing outputs must integrate seamlessly with the VA’s PALMS system and be delivered securely via vendor portal and fax, accompanied by a customer-accessible results portal. The lab must supply all collection kits and comply with DOT regulations for shipping biologic specimens, with strict labeling requirements tied to patient identification, specimen type, and collection date. Performance is subject to a Quality Assurance Surveillance Plan with a 95% target for meeting turnaround time limits and mandatory annual reporting on test usage and cost savings. The contractor is required to ensure all personnel meet stringent qualifications, including a licensed pathologist certified by the American Board of Pathology as laboratory director and CLIA-compliant certifications for all staff, with background investigations equivalent to VA employee standards. All data handling must adhere to VA security protocols, including FIPS 140-2 encryption for PHI, prohibition on unauthorized copying, immediate breach reporting to the Contracting Officer, and compliance with Title 38 restrictions on sensitive health records. Operations must occur within the United States, with no offshore processing unless specifically authorized. Subcontractors are bound by identical security and compliance obligations, and any personnel changes must be immediately reported. Invoicing is mandatory through the VA’s Electronic Invoice Presentment and Payment system using EFT; paper submissions are prohibited except under limited exceptions. The award will be made using a trade-off approach where technical capability outweighs price, with proposals evaluated based on their ability to meet clinical accuracy, timeliness, regulatory compliance, and system integration requirements. Offerors must maintain an active Unique Entity Identifier (UEI), self-certify their size status, and comply with mandatory FAR clauses on whistleblower rights, prohibitions on confidentiality agreements, and
260-NETWORK Contract Office 20 (36C260)

POSTED

2 days ago

DEADLINE

in 12 days
View Details
NAICS: 621511
New
Federal
BPA for Medical Laboratory Testing Services at 18th Medical Group - Kadena Air Base, Japan
Solicitation # HT941026Q2050
The contract is a Blanket Purchase Agreement (BPA) for Medical Laboratory Testing Services at the 18th Medical Group on Kadena Air Base, Japan, issued under solicitation number HT941026Q2050 by the Defense Health Agency Hcd West, Department of Defense. The BPA has a total ceiling value of $50,000 over its five-year period of performance from October 1, 2026, to September 30, 2031, and is structured as a firm-fixed-price agreement for specific laboratory tests including fungal culture and identification, TSPOT-TB testing, and antifungal drug susceptibility tests. The solicitation is unrestricted and invites full and open competition under NAICS code 621511. Contractors must submit a single PDF quotation that includes a capabilities statement addressing technical requirements from the Statement of Work, a completed Quote Sheet with firm-fixed pricing for each line item, and all required representations and certifications. Past performance and technical capability are critical evaluation factors, with technical capability serving as a mandatory pass/fail gate; failure to meet the technical threshold disqualifies a respondent. The evaluation is conducted on a best value basis with past performance carrying greater weight than price. Quote submissions are due by August 11, 2026, and must be emailed to the point of contact, April Delmendo. Performance is required on-site at the 18th Medical Group Laboratory in Building 626, Room LK08, during business hours of 7:30 a.m. to 4:30 p.m., Monday through Friday, excluding U.S. government holidays. The contractor must handle specimen collection daily within these hours, ensuring each sample includes the date, test name, patient name, and last four digits of the patient’s Social Security Number. The contractor is responsible for maintaining current laboratory accreditation, implementing a safety plan compliant with OSHA and Japan Environmental Governing Standards (JEGS), and ensuring all personnel have the necessary military base access credentials with background screening. Contractor staff must wear visible identification at all times and are prohibited from using retired or reserve military titles. Invoicing and payment will be processed electronically via the Wide Area Workflow system with specific routing and DoDAAC codes assigned. The contractor holds full liability for environmental incidents, property damage, and personnel injury, with mandatory reporting within one hour. The contract incorporates numerous FAR clauses related to cybersecurity, trafficking in persons, small
Defense Health Agency Hcd West

POSTED

2 days ago

DEADLINE

in 13 days
View Details

More opportunities from Department Of Defense → W7NH Uspfo Activity Msang 172

Same awarding agency